Nihon Kohden-Hemas Surgicals introduce next-gen Cereb Air EEG technology

Nihon Kohden’s team with College of Emergency Medicine President Dr. Inuka Wijewardena (third from left) at Sri Lanka College of Emergency Physicians’ Annual Academic Congress 2025

Nihon Kohden Singapore, a leading global medical device manufacturer from Japan, together with its local partner Hemas Surgicals and Diagnostics Limited, introduced the Cereb Air, a next-generation EEG monitoring solution, at the Annual Scientific Conference of the Sri Lanka College of Emergency Physicians (SLCEP). 
The event, held recently in Colombo, brought together leading emergency medicine professionals, researchers and healthcare stakeholders from across the country.
As platinum sponsor of the conference, Nihon Kohden highlighted its commitment to advancing neurological care by showcasing the Cereb Air. 
Nihon Kohden Global Product Manager Neurology Alejandro Ravago delivered a keynote presentation under the theme ‘New Generation EEG Monitoring’. He emphasised the device’s portability, wireless functionality and advanced data analytics, capabilities not found in conventional EEG systems. The presentation was met with strong interest and appreciation from participants, reflecting the growing demand for advanced neurological diagnostic tools in emergency care settings. Speaking about the introduction of Cereb Air, Hemas Pharmaceuticals Managing Director Dr. Mahesha Ranasoma said, “As a chapter in our mission to ‘Making Premium Healthcare Affordable’ for everyone, we’re invested in supporting strategies and developments that will effectively safeguard and protect lives. Our collaboration with Nihon Kohden Singapore and their outstanding work on the Cereb Air, resonates with many of our shared goals and values in not only saving lives but also advancing healthful living for all.” 
During the event, Sri Lanka College of Emergency Physicians President Consultant Dr. Inuka Wijegunawardena engaged in a discussion with the Nihon Kohden team on initiating a field study with Cereb Air. This study would explore its potential to enable rapid and accurate diagnosis of seizures among head injury patients, an area where timely clinical intervention could save lives. The collaboration also aims to assess the economic benefits for hospitals by reducing the need for unnecessary radiological imaging and avoiding preventable admissions.